Product Images Reclast
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Reclast NDC 0078-0435 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Zoledronic acid structural formula - reclast 01
Figure 1. Cumulative Incidence of Hip Fracture Over 3 Years - reclast 02
Figure 2. Therapeutic Response/Serum Alkaline Phosphatase (SAP) Normalization Over Time - reclast 03
PRINCIPAL DISPLAY PANELPackage Label – 5 mg / 100 mLRx Only NDC 0078-0435-61Reclast® (zoledronic acid) injection5 mg / 100 mLSolution for Intravenous InfusionDispense the accompanying Medication Guide to each patient.1 bottle – Sterile SolutionDo not mix with calcium-containing solutions. Administer as a single intravenous solution through a separate vented infustion line. - reclast 04
Reclast is a solution for intravenous infusion, containing 5mg/100mL of zoledronic acid. It is manufactured by Novartis and should be administered to patients following the accompanying Medication Guide. The solution is a sterile solution contained in a bottle. Recommended administration is through a vein over 15 minutes.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.